Verapamil potentiation of doxorubicin resistance development in B16 melanoma cells both in vitro and in vivo.

[1]  R. Ganapathi,et al.  Characterization in vitro and in vivo of progressively adriamycin-resistant B16-BL6 mouse melanoma cells. , 1987, Cancer research.

[2]  Y. Ostchega,et al.  Verapamil and adriamycin in the treatment of drug-resistant ovarian cancer patients. , 1987, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[3]  A. Hindenburg,et al.  Effect of verapamil and other agents on the distribution of anthracyclines and on reversal of drug resistance. , 1987, Cancer research.

[4]  C. Presant,et al.  Verapamil Reversal of Clinical Doxorubicin Resistance in Human Cancer A Wilshire Oncology Medical Group Pilot Phase I‐II Study , 1986, American journal of clinical oncology.

[5]  R. Supino,et al.  In vivo characterization of a doxorubicin resistant B16 melanoma cell line. , 1986, British Journal of Cancer.

[6]  R. Supino,et al.  Characterization of a doxorubicin-resistant murine melanoma line: studies on cross-resistance and its circumvention. , 1986, British Journal of Cancer.

[7]  M. Tseng,et al.  Verapamil enhancement of chemotherapeutic efficacy in human bladder cancer cells. , 1984, The Journal of urology.

[8]  R. Ozols,et al.  Reversal of adriamycin resistance by verapamil in human ovarian cancer. , 1984, Science.

[9]  F. Schabel,et al.  Induction and chemotherapeutic response of two transplantable ductal adenocarcinomas of the pancreas in C57BL/6 mice. , 1984, Cancer research.

[10]  M. Chitnis,et al.  In vitro enhancement of adriamycin cytotoxicity in human myeloid leukemia cells exposed to verapamil. , 1984, Oncology.

[11]  Z. Fuks,et al.  Reversal of acquired resistance to doxorubicin in P388 murine leukemia cells by perhexiline maleate. , 1984, Cancer research.

[12]  T. Tsuruo,et al.  Promotion by verapamil of vincristine responsiveness in tumor cell lines inherently resistant to the drug. , 1983, Cancer research.

[13]  S. Murray,et al.  Verapamil restoration of daunorubicin responsiveness in daunorubicin-resistant Ehrlich ascites carcinoma. , 1982, The Journal of clinical investigation.

[14]  T. Tsuruo,et al.  Increased accumulation of vincristine and adriamycin in drug-resistant P388 tumor cells following incubation with calcium antagonists and calmodulin inhibitors. , 1982, Cancer research.

[15]  A. Raz.  B16 melanoma cell variants: irreversible inhibition of growth and induction of morphologic differentiation by anthracycline antibiotics. , 1982, Journal of the National Cancer Institute.

[16]  T. Tsuruo,et al.  Overcoming of vincristine resistance in P388 leukemia in vivo and in vitro through enhanced cytotoxicity of vincristine and vinblastine by verapamil. , 1981, Cancer research.

[17]  T. Hirobe.  Stimulation of dendritogenesis in the epidermal melanocytes of newborn mice by melanocyte-stimulating hormone. , 1978, Journal of cell science.

[18]  B. Spengler,et al.  Membrane-mediated drug resistance and phenotypic reversion to normal growth behavior of Chinese hamster cells. , 1975, Journal of the National Cancer Institute.

[19]  R. Geran,et al.  PROTOCOLS FOR SCREENING CHEMICAL AGENTS AND NATURAL PRODUCTS AGAINST ANIMAL TUMORS AND OTHER BIOLOGICAL SYSTEMS , 1972 .